ALLENTOWN, PA / ACCESSWIRE / October 29, 2015 / Brainybrawn, Inc. (PINKSHEETS: BRNW) is pleased to announce a partnership with Microsoft India Private Limited, and a rollout of proprietary software HEALTHLYNX at hospitals nationwide. The first installation of SANVI HEALTHLYNX has successfully been completed at the prestigious Indian hospital Tata Memorial, as well as 11 others. Microsoft India Private Limited will be handling marketing, flow, distribution and delivery of SANVI's information management system for the medical industry through Microsoft India Sales Marketing and Services Group (SMSG). Through SMSG's existing relationships in the medical industry they have shown the ongoing value and systematic superiority of HEALTHLYX MD and RX to the outdated systems many of the hospitals were using.

The rollout of the SANVI HEALTHLYNX information management systems is ongoing and will continue for over 53 hospitals, including some of the most renowned hospitals in India; AIIMS, Apollo Hospitals, Fortis Hospitals, NIMHANS, and Tata Memorial Hospital. Current hospital contracts gross up to US$9,250,000 in annual reoccurring revenues for SANVI. Revenues are realized after each system is installed and will gradually ramp up to the total contracted number within the next three months. The current partnership divides incoming revenues equally between SANVI and Microsoft India Private Limited.

CEO Naresh Belwal said, "We couldn't be more pleased with the speed and direction of our partnership with Microsoft India Private Limited. Having an industry leader as a partner opens so many doors for SANVI and puts us on the fast track for market penetration and leadership in the near future."

HEALTHLYNX is a modular, integrated and complete out-patient, in-patient, electronic medical record ("EMR"), inventory, employee, supplies, finance, referral and business management solution for hospitals and multi-specialty nursing homes; HEALTHLYNX RX is an inventory, finance and business management solution for pharmaceutical retailers and wholesalers.

The market for SANVI's medical information systems is expanding significantly in India. According to a IBEF: The overall Indian healthcare market today is worth US$ 100 billion and is expected to grow to US$ 280 billion by 2020, a compound annual growth rate (CAGR) of 22.9 per cent.

In other areas, the company directors have agreed to reduce the authorized capital structure from 2,000,000,000 to 750,000,000. This reduction gives the company an attractive capital structure while at the same time leaving plenty of room for acquisitions and company expansion. We will announce a formal update regarding this matter in the near future.

Brainybrawn, Inc. is a software development & IT company, participating in the diversified industries by providing integrated and comprehensive information and business management solutions through its wholly owned subsidiary Sanvi Infotech Private Limited ("SANVI") headquartered in India.

SANVI has launched suites of customizable and comprehensive information management solutions for hospitals, doctors' offices, clinics, and pharmacies in the healthcare sector; for schools, colleges and medical colleges in the education sector; for hotels and restaurants in the hospitality and for single and chain stores in the retail sectors.

Microsoft India Private Limited is a subsidiary of American software company Microsoft Corporation, headquartered in Hyderabad, India the company has become a key IT partner of the Indian government and industry, supporting and fueling the growth of the local IT industry through its partner enablement programs.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact:

Brainybrawn, Inc.
investorrelations@brainybrawn.com

SOURCE: Brainybrawn, Inc.